A study to assess the safety and efficacy of rifampicin for progressive familial intrahepatic cholestasis (PFIC) and benign recurrent intrahepatic cholestasis (BRIC) A study to assess the safety and efficacy of rifampicinfor progressive familial intrahepatic cholest ...
A study to assess the safety and efficacy of rifampicin for progressive familial intrahepatic cholestasis (PFIC) and benign recurrent intrahepatic cholestasis (BRIC) - A study to assess the safety and efficacy of rifampicin for progressive familial intrahepatic cholestasis (PFIC) and benign recurrent intrahepatic cholestasis (BRIC) A study to assess the safety and efficacy of rifampicinfor progressive familial intrahepatic cholest ...
Rifampicin (RFP, 10 mg/kg/day) are given for 4-8 weeks. When RFP is effective against cholestasis, RFP will be tapered 2.5mg/kg per a week and withdrawn after 4 weeks. When bilirubin level does not decrease or the continuation of RFP is difficult for some side effects, RFP will be withdrawn. Rifampicin(RFP, 10 mg/kg/day) are given for 4-8 weeks. When RFPis effective against cholestasis, RFPw ...
Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University